Trial intelligence / Profile preview

Pre-induction fentanyl dosing strategy and postoperative nausea/vomiting after laparoscopic cholecystectomy

NL-OMON21891Not yet recruiting

Sponsor
Department of Anaesthesiology, Pain and Perioperative Medicine
Start
Mar 2011
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of fentanyl in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Department of Anaesthesiology, Pain and Perioperative Medicine. Primary endpoints: Impact of pre-induction IV fentanyl dosing methodology on reduction of PONV incidence and Reduction in postoperative antiemetic use. Planned start Mar 2011; status: not yet recruiting.

02

Drugs

fentanyl
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on NL-OMON21891.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON21891.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call